Mylan bids $205 a share for generic drug maker Perrigo
April 08, 2015 at 13:26 PM EDT
The deal will be worth $30 billion if executed, or a premium for Perrigo shareholders of 25%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
